Launch Sequence Aphrodisia Capsules, 4-count tins, ASIN B07QB3S2LV, UPC Code 661020846957.

FDA Recall #D-1338-2022 — Class I — June 27, 2022

Recall #D-1338-2022 Date: June 27, 2022 Classification: Class I Status: Terminated

Product Description

Launch Sequence Aphrodisia Capsules, 4-count tins, ASIN B07QB3S2LV, UPC Code 661020846957.

Reason for Recall

Marketed Without An Approved NDA/ANDA: Product found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

Recalling Firm

Loud Muscle Science — Hauppauge, NY

Classification

Class I — Reasonable probability of serious adverse health consequences or death.

Product Type

Drugs

Product Quantity

500 4-count tins

Distribution

The product was distributed nationwide in the USA and Canada.

Code Information

Lot # 2022104, exp. date 04/2025

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated

What Should You Do?

Stop using this medication immediately and contact your pharmacist or doctor. Do not flush medications down the drain. Return the product to the place of purchase for a refund or replacement.

Back to All Drug Recalls